FDA Requests Birth Defect Warning Added to Zoloft Label
The U.S. Food and Drug Administration (FDA) is urging Pfizer to add warning information to the label of its multi-billion dollar antidepressant drug, Zoloft. The agency requested that Pfizer change the warnings section of the drug’s prescribing information to include the findings of researchers who found an increased risk of congenital heart defects in newborns [...]